Cargando…
Reduction BACE1 expression via suppressing NF-κB mediated signaling by Tamibarotene in a mouse model of Alzheimer’s disease
This present study examined the effect of Tamibarotene (AM80) in APP/PS1 mice, a well-established AD mouse model. AM80 was intraperitoneal administered to 3-month-old APP/PS1 mice at a dose of 5 mg/kg/day for 16 weeks. The results clearly showed that AM80 could reduce amyloid-β peptides through impa...
Autores principales: | Qiao, Aimin, Li, Jieyi, Hu, Yaohua, Wang, Jinquan, Zhao, Zizhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019995/ https://www.ncbi.nlm.nih.gov/pubmed/33842919 http://dx.doi.org/10.1016/j.ibneur.2021.02.004 |
Ejemplares similares
-
Tamibarotene inhibit the accumulation of fibrocyte and alleviate renal fibrosis by IL-17A
por: Li, Lixi, et al.
Publicado: (2020) -
Carbon monoxide attenuates amyloidogenesis via down‐regulation of NF‐κB‐mediated BACE1 gene expression
por: Kim, Hyo Jeong, et al.
Publicado: (2018) -
Inclusion complex of tamibarotene with hydroxypropyl-β-cyclodextrin: Preparation, characterization, in-vitro and in-vivo evaluation
por: Yang, Ying, et al.
Publicado: (2017) -
Computational repurposing of tamibarotene against triple mutant variant of SARS-CoV-2
por: Mujwar, Somdutt
Publicado: (2021) -
Krüppel-like factor 5 accelerates the pathogenesis of Alzheimer’s disease via BACE1-mediated APP processing
por: Wang, Yaqi, et al.
Publicado: (2022)